Re:Covid vaccine: First ‘milestone’ vaccine offers 90% prote...
by evandijk70 on Monday November 09, 2020 @09:21AM
(#25035045)
Note that they provided 'Confirmed COVID-19 in Phase 2/3 participants without evidence of infection before vaccination [ Time Frame: From 7 days after the second dose of study intervention to the end of the study, up to 2 years ]'
as their primary outcome in their study registration
as their primary outcome in their study registration
https://clinicaltrials.gov/ct2/show/NCT04368728